PL1993577T3 - Stosowanie nieulegających trawieniu sacharydów dla zapewnienia niemowlęciu najlepszego startu po narodzinach - Google Patents

Stosowanie nieulegających trawieniu sacharydów dla zapewnienia niemowlęciu najlepszego startu po narodzinach

Info

Publication number
PL1993577T3
PL1993577T3 PL07715912T PL07715912T PL1993577T3 PL 1993577 T3 PL1993577 T3 PL 1993577T3 PL 07715912 T PL07715912 T PL 07715912T PL 07715912 T PL07715912 T PL 07715912T PL 1993577 T3 PL1993577 T3 PL 1993577T3
Authority
PL
Poland
Prior art keywords
sacharides
digestable
infant
birth
giving
Prior art date
Application number
PL07715912T
Other languages
English (en)
Inventor
Christopher Beermann
Jan Knol
Martine Sandra Alles
Bernd Stahl
Günther Boehm
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of PL1993577T3 publication Critical patent/PL1993577T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Seeds, Soups, And Other Foods (AREA)
PL07715912T 2006-03-10 2007-03-09 Stosowanie nieulegających trawieniu sacharydów dla zapewnienia niemowlęciu najlepszego startu po narodzinach PL1993577T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP06110973 2006-03-10
EP06112822 2006-04-20
PCT/NL2007/050094 WO2007105945A2 (en) 2006-03-10 2007-03-09 Use of non-digestable sacharides for giving an infant the best start after birth
EP07715912.7A EP1993577B1 (en) 2006-03-10 2007-03-09 Use of non-digestable sacharides for giving an infant the best start after birth

Publications (1)

Publication Number Publication Date
PL1993577T3 true PL1993577T3 (pl) 2014-07-31

Family

ID=38349460

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07715912T PL1993577T3 (pl) 2006-03-10 2007-03-09 Stosowanie nieulegających trawieniu sacharydów dla zapewnienia niemowlęciu najlepszego startu po narodzinach

Country Status (16)

Country Link
US (2) US20090305996A1 (pl)
EP (2) EP1993577B1 (pl)
JP (1) JP2009529574A (pl)
CN (2) CN101420966B (pl)
AR (1) AR059817A1 (pl)
AU (2) AU2007225549B2 (pl)
BR (1) BRPI0708701A2 (pl)
CA (2) CA2883256A1 (pl)
DK (1) DK1993577T3 (pl)
ES (1) ES2459621T3 (pl)
MY (2) MY191118A (pl)
NZ (1) NZ571158A (pl)
PL (1) PL1993577T3 (pl)
PT (1) PT1993577E (pl)
RU (1) RU2462252C2 (pl)
WO (1) WO2007105945A2 (pl)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
CN101420966B (zh) 2006-03-10 2013-07-17 纽崔西亚公司 不可消化的糖用于在出生后给予婴儿最佳开始的用途
AU2008324105B2 (en) * 2007-11-08 2014-01-30 Société des Produits Nestlé S.A. Use of oligosaccharides containing N-acetyllactosamine for maturation of immune responses in neonates
BRPI0821165B8 (pt) 2007-12-07 2021-05-25 Nutricia Nv uso de uma composição
EP2072052A1 (en) * 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
PT2265135T (pt) * 2008-03-14 2018-02-21 Nestec Sa Mistura simbiótica
ES2550499T3 (es) * 2008-03-28 2015-11-10 Nestec S.A. Probióticos de uso en mamíferos hembra gestantes para aumentar la inmunidad de sus crías
EP2110027A1 (en) * 2008-04-01 2009-10-21 Nestec S.A. Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation
SG10201901259RA (en) 2009-02-24 2019-03-28 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
US8785160B2 (en) 2009-02-24 2014-07-22 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
WO2011008086A1 (en) 2009-07-15 2011-01-20 N.V. Nutricia Mixture of non-digestible oligosaccharides for stimulating the immune system
PL2453901T3 (pl) 2009-07-15 2015-03-31 Nutricia Nv Fukozyloklaktoza jako identyczny z mlekiem kobiecym niestrawny oligosacharyd do leczenia i/lub zapobiegania infekcji wirusowych
EP2465507A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating skin diseases
EP2465508A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
EP2454948A1 (en) * 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
US8802650B2 (en) 2010-12-31 2014-08-12 Abbott Laboratories Methods of using human milk oligosaccharides for improving airway respiratory health
CN107019701B (zh) 2010-12-31 2020-07-28 雅培制药有限公司 使用人乳低聚糖来降低婴儿、幼儿或儿童的坏死性小肠结肠炎的发病率的方法
ES2667393T3 (es) 2010-12-31 2018-05-10 Abbott Laboratories Oligosacáridos de leche humana para modular inflamación
WO2012092155A1 (en) * 2010-12-31 2012-07-05 Abbott Laboratories Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
CA2822490C (en) 2010-12-31 2020-03-31 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
MY166945A (en) 2010-12-31 2018-07-25 Abbott Lab Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
MY191538A (en) 2010-12-31 2022-06-30 Abbott Lab Human milk oligosaccharides to promote growth of beneficial bacteria
ES2804258T3 (es) 2010-12-31 2021-02-05 Abbott Lab Procedimientos para reducir la incidencia de estrés oxidativo usando oligosacáridos de leche humana, vitamina C y agentes antiinflamatorios
DE102011012494A1 (de) * 2011-02-25 2012-08-30 Humana Milchunion Eg Prebiotische Kohlenhydrat-Zusammensetzungen
WO2012177118A1 (en) * 2011-06-22 2012-12-27 N.V. Nutricia Method for reducing the occurrence of infection in young children
EP2734210B1 (en) 2011-07-22 2017-11-22 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
NL2007268C2 (en) 2011-08-16 2013-02-19 Friesland Brands Bv Nutritional compositions comprising human milk oligosaccharides and uses thereof.
CA2846603A1 (en) 2011-08-29 2013-03-07 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
DK2811845T3 (en) * 2012-02-10 2016-03-14 Nutricia Nv GRANT TO MOTHERS FOR STRENGTHENING OF A baby's immune system
EP2830712A1 (en) * 2012-03-27 2015-02-04 Abbott Laboratories Methods for modulating cell-mediated immunity using human milk oligosaccharides
WO2013161820A1 (ja) * 2012-04-23 2013-10-31 国立大学法人京都大学 ビフィズス菌の増殖促進用組成物
SG11201608248YA (en) 2014-04-08 2016-10-28 Abbott Lab Methods for enhancing mucosal innate immune responses to and/or detection of pathogens using human milk oligosaccharides
WO2016043583A1 (en) * 2014-09-15 2016-03-24 N.V. Nutricia Reducing anxiety in progeny
RU2731154C2 (ru) * 2015-03-05 2020-08-31 Сосьете Де Продюи Нестле С.А. Композиция для применения в улучшении консистенции или частоты стула у младенцев или детей младшего возраста
RU2724590C2 (ru) * 2015-08-04 2020-06-25 Сосьете Де Продюи Нестле С.А. Питательные композиции с 2fl и lnnt для применения при индукции кишечной микробиоты, которая похожа на кишечную микробиоту младенцев на грудном вскармливании
PL3377071T3 (pl) 2015-11-17 2024-06-24 Glycom A/S Oligosacharydy mleka ludzkiego do leczenia powikłań związanych z antybiotykami
JP6993340B2 (ja) * 2016-01-26 2022-02-03 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 経表皮水分損失を予防又は低減するための組成物
AU2017230187A1 (en) * 2016-03-11 2018-10-04 Infinant Health, Inc A transient commensal microorganism for improving gut health
EP3592363B1 (en) * 2017-03-08 2026-02-25 N.V. Nutricia Composition with galacto-oligosaccharides and fructo-oligosaccharides for treating non-allergic rhinitis
PH12019550208B1 (en) * 2017-05-24 2024-05-24 Socia‰Ta‰ Des Produits Nestla‰ S A Hmos blends for use in infants or young children for health purposes
WO2019031961A1 (en) 2017-08-11 2019-02-14 N.V. Nutricia OLIGOSACCHARIDE OF HUMAN MILK TO IMPROVE PHYSICAL IMMUNE CONDITION
EP3672600A4 (en) 2017-08-21 2021-05-19 Glycom A/S SYNTHETIC COMPOSITION TO REDUCE ALLERGY SYMPTOMS
CN113163836A (zh) * 2018-06-01 2021-07-23 进化生物系统股份有限公司 促进宿主防御和刺激、扩增和/或重置t细胞库的组合物和方法
TW202128190A (zh) * 2019-10-24 2021-08-01 荷蘭商弗里斯蘭康必奶荷蘭有限公司 用於預防氣喘的包含2’-岩藻糖基乳糖之組成物
JP7833397B2 (ja) * 2019-11-29 2026-03-19 グリコム・アクティーゼルスカブ 妊婦の細菌叢を改善するためのｈｍｏの混合物
JP7563732B2 (ja) * 2019-12-04 2024-10-08 株式会社希松 飲食品組成物、肌改善用飲食品組成物、肌改善用および便秘改善用飲食品組成物
JP7813333B1 (ja) * 2024-11-08 2026-02-12 日本食品化工株式会社 膣常在菌叢バランス改善剤及び膣用組成物

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
NL9401644A (nl) 1994-10-06 1996-05-01 Friesland Brands Bv Voedingsmiddel voor zwangere en lacterende vrouwen
GB9808579D0 (en) * 1998-04-22 1998-06-24 Novartis Nutrition Ag Improvements in or relating to organic compounds
DE19836339B4 (de) * 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
RU2132695C1 (ru) * 1998-12-10 1999-07-10 Кричков Андрей Германович Средство для профилактики токсикоза первой половины беременности эйр-1
FI110668B (fi) 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
RU2213493C2 (ru) * 2001-05-29 2003-10-10 Устинова Александра Васильевна Консервы на мясной основе для питания беременных и кормящих женщин
US6596313B2 (en) * 2001-08-06 2003-07-22 The Quigley Corporation Nutritional supplement and methods of using it
DE10147100A1 (de) * 2001-09-25 2003-04-17 Numico Res B V Antiinfektive Kohlenhydrate
RU2262867C2 (ru) * 2002-02-14 2005-10-27 Катков Юрий Адольфович Бад к пище для улучшения репродукции человека (варианты)
EP1344458A1 (en) * 2002-03-12 2003-09-17 Société des Produits Nestlé S.A. Probiotic delivery system
DE60322570D1 (de) * 2002-06-28 2008-09-11 Puleva Biotech Sa Probiotische stämme, verfahren zur ihren selektion, diese enthaltende zusammensetzungen und ihre verwendung
WO2004012655A2 (en) * 2002-08-06 2004-02-12 The Quigley Corporation Anti-microbial compositions and methods of using same
US20050015018A1 (en) 2003-05-23 2005-01-20 Dolphin William F. Ear probe and disposable ear tip system
CN1863463B (zh) * 2003-06-23 2011-05-04 雀巢技术公司 用于促进肠道屏障成熟的营养组合物
ES2781848T3 (es) * 2003-10-24 2020-09-08 Nutricia Nv Oligosacáridos inmunomoduladores
ES1056525Y (es) * 2004-01-13 2004-07-16 Perez Alfredo Pineiro Halador de tres rodillos para redes y aparejos de pesca.
CN1562049A (zh) * 2004-04-02 2005-01-12 聂四平 低聚果糖在制备治疗及预防阴道炎药中的应用
EP1597978A1 (en) * 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US20060233772A1 (en) * 2005-04-15 2006-10-19 Udo Herz Method for preventing or treating the development of respiratory allergies
US7303745B2 (en) * 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
CN101420966B (zh) 2006-03-10 2013-07-17 纽崔西亚公司 不可消化的糖用于在出生后给予婴儿最佳开始的用途

Also Published As

Publication number Publication date
US20150250807A1 (en) 2015-09-10
EP1993577B1 (en) 2014-02-12
CN103315205A (zh) 2013-09-25
CA2645472A1 (en) 2007-09-20
NZ571158A (en) 2011-08-26
ES2459621T3 (es) 2014-05-12
EP1993577A2 (en) 2008-11-26
JP2009529574A (ja) 2009-08-20
PT1993577E (pt) 2014-05-27
CN101420966B (zh) 2013-07-17
WO2007105945A3 (en) 2007-11-08
CN101420966A (zh) 2009-04-29
RU2008140167A (ru) 2010-04-20
AU2012265617B2 (en) 2016-02-25
DK1993577T3 (da) 2014-05-12
RU2462252C2 (ru) 2012-09-27
AR059817A1 (es) 2008-04-30
CA2883256A1 (en) 2007-09-20
AU2012265617A1 (en) 2013-01-10
WO2007105945A2 (en) 2007-09-20
CA2645472C (en) 2015-09-15
BRPI0708701A2 (pt) 2011-06-07
US20090305996A1 (en) 2009-12-10
EP2388010A1 (en) 2011-11-23
US9872869B2 (en) 2018-01-23
MY191118A (en) 2022-05-30
AU2007225549B2 (en) 2012-09-27
MY168792A (en) 2018-12-04
AU2007225549A1 (en) 2007-09-20

Similar Documents

Publication Publication Date Title
IL250435A0 (en) Using hil-2-mutein of human origin to prepare a factor for the production of regulatory t cells
IL200272A0 (en) Progesterone for the prevention of preterm birth
EP2076194A4 (en) SYSTEM FOR GENERATING DESIRED TEMPERATURE EFFECTS ON BODY TISSUE
EP2078051A4 (en) PROCESS FOR PRODUCTION OF POLYSILOXANES AND USE THEREOF
GB2442586B (en) Infant accommodation apparatus
EP2078536A4 (en) MEDICAL DEVICE
IL193604A (en) Use of human anti-22 @ il antibodies for @ preparation
EG24893A (en) Apparatus for the connection of strips
SI2054088T1 (sl) Naprava za obdelavo vsebnikov
SI2362764T1 (sl) Naprava za mobiliziranje telesa
EP2117330A4 (en) PROCESS FOR THE PREPARATION OF ANGIOGENIN
EP2192905A4 (en) METHOD FOR SELECTIVE THERAPY OF DISEASE
ZA200900336B (en) Process for the preparation of diesters
GB0909840D0 (en) Thermal tramsfer device for human body
GB0612096D0 (en) Functional imaging of the retina
ZA200907191B (en) Process for the preparation of gefitiib
PL1976960T3 (pl) Sposób wytwarzania biooleju napędowego
EP2066524A4 (en) APPARATUS FOR THE TREATMENT OF ANIMALS
IL193669A0 (en) Apparatus for the treatment of bruxism
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
ZA200901556B (en) Process for the preparation of abacavir
GB2464854B (en) Process for the preparation of risperidone
SG136107A1 (en) Pantsuit for an infant
EP2068789A4 (en) DEVICE FOR CHANGING THE BODY TEMPERATURE OF A PATIENT
IL197408A0 (en) Process for the preparation of abacavir